GSK M&A Summary
GSK has acquired 35 companies, including 9 in the last 5 years. A total of 5 acquisitions came from private equity firms. It has also divested 24 assets.
GSK’s largest acquisition to date was in 2000, when it acquired SmithKline Beecham for $75.7B. It’s largest disclosed sale occurred in 2013, when it sold Lucozade Ribena Suntory to Suntory Beverage & Food for $2.1B. GSK has acquired in 11 different US states, and 10 countries. The Company’s most targeted sectors include life science (80%) and medical products (9%).
M&A Summary
-
M&A Total Activity59
- M&A Buy Activity35
- M&A Sell Activity24
- Total Sectors Invested 5
- Total Countries Invested 10
- M&A Buy/Sell Connections 32
Unlimited Searches
